Louis Citarelli
Internal Medicine · Nutley, NJNPI 1063520484
Payments from drug & device makers
Across 295 payments — averaging $14.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$769
- Boehringer Ingelheim$446
- Novo Nordisk$439
- Amarin Pharma, Inc.$388
- Lilly USA, LLC$339
- Merck$325
- plus $2K from 23 others
What the payments were for
- Consulting fees$1002%
- Food & beverage$4,16398%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 44 | $769 |
| Boehringer Ingelheim | 17 | $446 |
| Novo Nordisk | 43 | $439 |
| Amarin Pharma, Inc. | 29 | $388 |
| Lilly USA, LLC | 28 | $339 |
| Merck | 25 | $325 |
| Amgen(2 entities) | 24 | $281 |
| AbbVie(2 entities) | 18 | $247 |
| Kowa Pharmaceuticals America, Inc. | 9 | $117 |
| Johnson & Johnson(2 entities) | 6 | $116 |
| GSK | 8 | $104 |
| Comsort, Inc | 1 | $100 |
| Endo Pharmaceuticals Inc. | 7 | $98 |
| Esperion Therapeutics, Inc. | 6 | $77 |
| Zyla Life Sciences, Inc. | 4 | $58 |
| Paratek Pharmaceuticals, Inc. | 4 | $56 |
| Indivior Inc. | 4 | $55 |
| Clarus Therapeutics Inc. | 4 | $42 |
| Orthogenrx Inc. | 2 | $33 |
| Eisai Inc. | 2 | $27 |
| Pfizer | 2 | $27 |
| Bioventus LLC | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Avanos Medical | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Circassia Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Aytu Biopharma, Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,269 in reported general payments places this provider in the 85th percentile of 4,032 internal medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $5,764 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 19 | $3,274 |
| Levothyroxine Sodium | 17 | $310 |
| Metoprolol Succinate | 13 | $224 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $169 |
| Atorvastatin Calcium | 17 | $147 |
| Bumetanide | 11 | $125 |
| Amlodipine Besylate | 12 | $118 |
| Pantoprazole Sodium | 12 | $79 |
| Clonazepam | 12 | $71 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Indivior Inc.Suboxone | $55 | $5,76413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,032 internal medicine providers in New Jersey.
Other internal medicine in Nutley
- Sanjiv SharmaToms River$33.9M
- Jeffrey CarsonNew Brunswick$13.8M
- Samer HaddadHamilton$6.8M
- Magdy ShenoudaWall$3.7M
- Samar HameedLivingston$3.6M
- Jane RohlfTrenton$2.7M
- Mohammed NisarEdison$2.6M
- Michael CasserNew Milford$2.2M
- Sumitha ReddyHamilton$2M
- Helio PedroNewark$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.